✦ LIBER ✦

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250mg With Fulvestrant 500mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

✍ Scribed by Jordan, V.C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NEWEST: a Phase II, randomised, neoadjuv

✍ C. Singer; I. Kuter; R. Hegg; R. Badwe; N. Harbeck; J. Bines; E. Lowe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

5080 Safety and tolerability of fulvestr

✍ N. Gottschalk; I. Kuter; J.F. Robertson; M.J. Ellis; J. Lindeman; I. Schrader; B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Phase II Trial of Exemestane in Combinat

✍ Ewa Mrózek; Rachel Layman; Bhuvaneswari Ramaswamy; Larry Schaaf; Xiaobai Li; Sus 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 354 KB

Results of a phase II study comparing th

✍ Kathleen I. Pritchard; Janusz Rolski; Zsuzsanna Papai; Louis Mauriac; Fatima Car 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 363 KB

5072 Independent central review of clini

✍ J.P.O. Lindemann; J.F.R. Robertson; M.J. Ellis; Y. Menu; E.J. Macpherson; D.D.C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Phase II Trial of Fulvestrant With Metro

✍ Schwartzberg, Lee S.; Wang, Grace; Somer, Bradley G.; Blakely, L. Johnetta; Whee 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 276 KB